Colossal Biosciences

investment firm

About

Colossal is a breakthrough bioscience and genetic engineering company that builds radical new technologies to advance the field of genomics.

Details

Last Funding Type
Series A
Last Funding Money Raised
$60M
Industries
Biotechnology,Genetics,Life Science
Founded date
Feb 4, 2021
Operating Status
Active
Legal Name
Colossal Biosciences, Inc.
Also Known As
Colossal

Colossal creates disruptive technologies for extinct species restoration, critically endangered species protection and the repopulation of critical ecosystems that support the continuation of life on Earth. The company is the first to apply CRISPR technology for the purposes of species de-extinction, beginning with the woolly mammoth. Colossal is accepting humanity’s duty to restore Earth to a healthier state, while also solving for the future economies and biological necessities of the human condition through cutting-edge science and technologies.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
3
$75M
Colossal Biosciences has raised a total of $75M in funding over 2 rounds. Their latest funding was raised on Oct 3, 2022 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Oct 3, 2022 Series Unknown 1 In-Q-Tel Detail
Mar 9, 2022 Series A $60M 19 At One Ventures
Thomas Tull
Detail
May 6, 2021 Seed $15M 17 Thomas Tull Detail

Investments

Number of Investments
Number of Lead Investments
4
1
Colossal Biosciences has made 4 investments. Their most recent investment was on Dec 5, 2022, when Runway raised $50M.
Date Company Name
Round Money Raised Industry Lead Investor
Dec 5, 2022 Runway
Series C $50M Artificial Intelligence
Dec 5, 2022 Twelve Labs
Seed $12M Information Technology
Jan 22, 2020 Front
Series C $59M Collaboration Yes
Jun 17, 2019 Clockwise
Series A $11.30M Enterprise Software

Investors

Number of Lead Investors
Number of Investors
4
29
Colossal Biosciences is funded by 29 investors. In-Q-Tel and At One Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
In-Q-Tel Yes Series Unknown
At One Ventures Yes Series A
Thomas Tull Yes Series A
11:11 Media Series A
Animal Capital Series A
Animoca Brands Series A
Bold Capital Partners Series A
Boost VC Series A
Breyer Capital Series A
Builders VC Series A

Employee Profiles

Number of Employee Profiles
14
Colossal Biosciences has 14 current employee profiles, including Executive George Church
Executive
Executive
Executive
Executive
Executive